Best stocks to buy (AI image)
Stock market recommendations: IBCA Laboratoriesand African Union Microfinance Bank These are the stocks that Motilal Oswal Wealth Management Research recommends you buy for the week beginning March 30, 2026. Target prices and potential upsides are listed below:
| Stock name | CMP (Rs) | Target (Rs) | Upside down (%) |
| IBCA Laboratories | 1595 | 1820 | 14% |
| African Union Bank | 883 | 1250 | 42% |
IBCA LaboratoriesIpca Laboratories is witnessing an improvement in growth outlook driven by recovery in domestic formulations business and gradual recovery in exports. The company is strengthening its domestic portfolio by expanding into cardiology, pain management, and foray into cutting-edge dermatology, while strengthening key brands like Zerodol.
Export growth is supported by increasing traction in branded markets and a steady increase in generic medicines, aided by product relaunch in the US and participation in European tenders. Unichem’s business integration is progressing, with a focus on improving cost efficiencies through API integration and rebuilding the product pipeline, although near-term performance remains impacted by pricing pressures.
Overall, improved operating leverage, portfolio optimization and better execution across segments enable the company to achieve consistent earnings growth.African Union Microfinance BankAfrican Microfinance Bank’s transformation from an SFB to a global bank expands its addressable market across retail, SME and medium enterprise lending, while lower priority sector requirements and broader product capabilities improve portfolio flexibility, cross-selling opportunities and long-term return potential.
A finer deposit base, improved current and savings account mix and expansion of the network of more than 2,700 touchpoints support growth in liability and operational leverage. A heavy secured loan portfolio and disciplined underwriting are expected to keep credit costs contained, supporting sustainable profitability over the long term. Loans are expected to grow at a CAGR of 24% during FY26-28, driven by a strong branch-led distribution network and expansion across secured lending segments.
This, coupled with moderate funding costs and stable asset quality, is likely to drive an earnings CAGR of 36% over FY26-28.(Disclaimer: Recommendations, opinions regarding stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times Of India)